Skip to content

Comparison of the Effectiveness, Safety, and Satisfaction of Different Methods for Labor Induction

Comparison of the Effectiveness, Safety, and Satisfaction of Different Methods for Labor Induction

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06794385
Enrollment
200
Registered
2025-01-27
Start date
2025-01-22
Completion date
2025-12-01
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labour

Keywords

misoprostol, induction of labour, dinoprostone

Brief summary

The objective of this interventional study is to compare the effectiveness, safety, and patient satisfaction associated with two commonly used methods of labor induction: low-dose oral misoprostol and the vaginal delivery system with dinoprostone. The study aims to identify the most suitable induction method for specific subgroups of patients based on parity, body mass index (BMI), age, and cervical ripeness, as well as assess patient preferences for these induction methods.

Interventions

DRUGdinoprostone vaginal delivery system

Pregnant women in this group will receive a vaginal delivery system containing 10 mg of dinoprostone for labor induction.

DRUGlow dose peroral misoprostol

Participants will be induced with a low-dose oral formulation of misoprostol, administered per protocol at 25 mcg every 2 hours

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Gestational age between 37 0/7 and 42 0/7 weeks * Singleton pregnancy * Viable fetus in cephalic presentation * Bishop score ≤ 6 * Maximum parity of three * Reactive CTG at admission without pathological findings

Exclusion criteria

* Age \< 18 years * Gestational age \< 37 0/7 weeks * Active labor * Spontaneous rupture of membranes * Non-reassuring CTG findings * Suspected infection (e.g., fever \> 38°C, chorioamnionitis, or unexplained systemic infection) * Contraindications to vaginal delivery or prostaglandin use * Previous cesarean delivery or uterine surgery involving entry into the uterine cavity * Significant fetal abnormalities * Severe fetal growth restriction with an estimated fetal weight below the 3rd percentile * Non-Slovenian-speaking participants

Design outcomes

Primary

MeasureTime frameDescription
Time from induction to delivery1 week from inductionThe time from the insertion of the vaginal delivery system or administration of the oral tablet to the time of delivery

Secondary

MeasureTime frameDescription
Time from induction to spontaneos vaginal delivery1 week from inductionThe time from the insertion of the vaginal delivery system or administration of the oral tablet to the time of spontaneous vaginal delivery
Time from induction to onset of active labour1 week from inductionThe investigators will measure the time from the insertion of the vaginal delivery system or administration of the oral tablet to the onset of active labor, defined as the occurrence of strong contractions every 5 minutes.
Use of oxytocin and its dosage1 week from inductionThe investigators will compare the need for oxytocin administration and its dosage, measured in international units (IU).
Use of analgesia during labour1 week from inductionThe need for epidural analgesia, remifentanil, N₂O, no analgesia.
Type of delivery1 week from inductionVaginal birth, Caesarean birth, Vacuum extraction
Hyperstimulation with nonreassuring fetal heart rate tracing1 week from inductionRate of uterine hyperstimulation- exaggerated uterine response consisting of uterine hypertonus, a single uterine contraction lasting two or more minutes or uterine tachysystole with a least 12 contractions in 20 minutes, with a simultaneous nonreassuring fetal heart rate tracing as defined by the 2015 FIGO (The international federation of gynaecology and obstetrics) classification of intrapartum cardiotocography.
Duration of labour1 week from inductionTime from the onset of labor (regular contraction every 5 minutes) to the delivery of the baby
Postpartum hemorrhage above 1000 mL1 week from inductionThe investigators will assess whether participants experience blood loss exceeding 1000 mL during delivery and within the first 3 hours postpartum.
Number of participants with fourth degree tear of perineum during labour1 week from inductionThe investigators will observe the occurrence of fourth-degree perineal tears during labor. A fourth-degree tear involves injury to the anal sphincter complex (EAS and IAS) as well as the anorectal mucosa.
Side effects of misoprostol and dinoprostone1 week from inductionThe investigators will monitor for the occurrence of the following side effects: nausea, vomiting, high fever, discomfort, diarrhea, and allergic reactions.
Number of newborns wtih 5-minute APGAR score of less than 71 week from inductionInfants with a 5-minute APGAR score of less than 7.The Apgar score is a number calculated by scoring the heart rate, respiratory effort, muscle tone, skin color, and reflex irritability of the infant, 5 min after birth. Each of these objective signs can receive 0, 1, or 2 points. The higher is the sum of the points, the better is the condition of the newborn. 5-minute APGAR score of less than 7.
pH from umbilical artery1 week from inductionA sample will be taken from the umbilical artery after birth for pH analysis.
Number of newborns admitted to intensive care unit3 weeks from inductionInfants which will be admitted to the neonatal intensive unit for whatever reason.
Satisfaction with induction1 week from inductionAll participants will complete questionnaires designed to assess whether they experienced any feelings of coercion or undue pressure when consenting to labor induction. These surveys will include four questions specifically focused on labor induction, with responses measured using a Likert scale. The questionnaires will be administered after participants have agreed to proceed with the induction process.
Satisfaction with childbirth3 weeks from inductionThe second questionnaire, the validated Childbirth Experience Questionnaire (CEQ2), assesses satisfaction with the labor and delivery process. Participants will complete the CEQ2 within the first three days postpartum while still admitted to the maternity ward. The survey comprises 22 statements specifically addressing aspects of labor induction and the childbirth experience, with responses evaluated using a Likert scale.
Number of participants with third degree tear of perineum during labour1 week from inductionThe investigators will observe the occurrence of third-degree perineal tears during labor. A third-degree tear involves injury to the anal sphincter complex, classified as follows: 3a involves less than 50% of the external anal sphincter (EAS) being torn, 3b involves more than 50% of the EAS being torn, and 3c involves tearing of both the EAS and the internal anal sphincter (IAS).

Countries

Slovenia

Contacts

Primary ContactPOLONA PEČLIN
polona.peclin@kclj.si0038615226162

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026